Furthermore, expression of VEGFR-2 by tumor cells in addition to its constitutive presence on endothelial cells in glioblastoma has been controversial, though there has been increasing evidence for a restricted expression of VEGFR-2 in a subset of tumor cells [12–16]. This evidence concerns the gene KDR and neoplasm.